Ekokobe Fonkem, DO, is the Chief of Neuro-Oncology at the Barrow Neurological Institute and Associate Professor of Neurology at the University of Arizona College of Medicine and Creighton University College of Medicine. His research focus in Neuro-Oncology involves translational, clinical, and quality of life research on newly diagnosed and recurrent brain tumors.
His work includes many basic, translational, and clinical research studies. Recently, he co-authored an article showing that SMARCB1 gene mutation predisposes to earlier development of glioblastoma.
Dr. Fonkem has published 40 research articles in well-respected publications, such as the Journal of Clinical Oncology, the Journal of American Chemical Society, and Neuro-Oncology, as well as half a dozen book chapters in his field. Additionally, Dr. Fonkem has shared his research in numerous presentations to national and international organizations, including the Society for Neuro-Oncology, the Society of Neuro-Oncology China, the Society of Neuro-Oncology Sub Saharan Africa, the American Society of Clinical Oncology, and the American Academy of Neurology.
Dr. Fonkem finds inspiration in passionately working with his team of accomplished faculty and staff at the Barrow Neurological Institute to bring the most advanced treatment for his patients with brain and spine tumors. He strongly believes that together, we can make a real difference in the lives of our patients.